Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Expression Analysis Announces 2013 Grant Program

Published: Monday, April 08, 2013
Last Updated: Monday, April 08, 2013
Bookmark and Share
Two recipients to receive cutting-edge services from Expression Analysis and Illumina to advance new applications in genomics research.

Expression Analysis (EA), a Quintiles company today announced a grant program that provides scientists with leading-edge products and services to advance genomics research. In the fifth year of EA’s grant program, EA and Illumina will award two grant winners fully-funded exome and RNA sequencing services along with array-based methylation analysis as part of the companies’ integrated biology grant.

“This grant program illustrates our commitment to advancing new applications in genomics research,” said Steve McPhail, President of EA. “We are encouraging researchers to explore the power of an integrated biological approach in their genetic research studies.”

“We are very excited to enable this comprehensive approach using the latest advances in genomic studies enhanced with gene expression and regulation,” said Tristan Orpin, Senior Vice President and Chief Commercial Officer of Illumina. “We look forward to another successful partnership with EA in co-sponsoring these grants.”

Integrated biology is a scientific approach that has considerable advantages over other approaches within biology and biomedical research—including interpreting interactions in genetic research studies through a comprehensive, systems view rather than a single scientific lens that can exclude significant biological factors.

The integrated biology grant includes:

•    Whole Genome DNA Methylation, which plays a critical role in the regulation of gene expression and is known to be an essential mechanism for guiding normal cellular development and maintaining tissue identities;
•    RNA Sequencing, which enables a more comprehensive and quantitative view of the entire transcriptome, providing accurate analysis of gene expression. This also enables identification of novel transcripts, novel isoforms, alternative splice sites, allele-specific expression, cSNPs, and rare transcripts all in a single experiment; and
•    Exome Sequencing, which integrates protein coding regions of the human genome through enrichment strategies that target all exons, UTRs and other functionally annotated regions of interest.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

EPA Awards $27 Million Contract to Expression Analaysis
Renewed contract for expansion of ToxCast's genomic data.
Thursday, August 09, 2012
Expression Analysis Announces RNA-SEQ Grant Program
EA teams with Golden Helix and Illumina to offer three fully-funded grants for RNA-Seq studies.
Tuesday, February 21, 2012
Expression Analysis Welcomes New Vice President of Operations
EA announces the addition of Tyler Aldredge to its executive management team. Tyler will assume the role of Vice President of Laboratory Operations.
Wednesday, September 21, 2011
Expression Analysis Hires Director of Business Development
Expression Analysis announces that Jeff Fitzgerald has joined their management team as Director of Business Development.
Friday, September 09, 2011
EA Announces Research Acceleration Grant Focusing on Kinase Mutations and Cancer
Company announces research grant to investigate and draw parallels between specific cancers and recurring mutations in specific kinases, using targeted genome sequencing.
Thursday, February 03, 2011
Expression Analysis® Receives CLIA Certification
The company enters its tenth year of providing genomic expertise; something the company refers to as “Genomic Know-How™”.
Wednesday, February 02, 2011
Expression Analysis and Illumina Fund GWAS and Data Analysis Grant Program to Support Cancer Research
Illumina to provide microarrays and reagents while Expression Analysis will perform services and data analysis consultation at no cost to the recipient of the selected study.
Wednesday, November 03, 2010
Expression Analysis® Expands Scientific Management Team
Expression Analysis, Inc. has announced two additions to its scientific management team Patrick Hurban, Ph.D. and Louise Grant.
Wednesday, April 28, 2010
Expression Analysis Launches a new Website and Offers Scientists
The redesigned website allows researchers and scientists to easily navigate and locate the information and services.
Thursday, August 06, 2009
Expression Analysis Adopts Cure Kids Cancer Coalition
Fund-raising will begin at Upcoming American Society of Human Genetics Meeting.
Monday, November 03, 2008
Expression Analysis Announces a GWAS Data Analysis and Resequencing Grant
Expression Analysis, the industry’s leading provider of genomic services for clinical trials and research, announces they will award a Genome Wide Association Study (GWAS) Data Analysis and Resequencing Grant.
Thursday, October 02, 2008
Expression Analysis Awarded EPA Contract for ToxCast™ Genomic Services
Expression Analysis will provide gene expression and genotyping services for EPA's ToxCast™ Program.
Friday, April 13, 2007
Expression Analysis Relocates to Larger Laboratory Facility While Expanding its Genomic Services and Staff
The Company moves to new facility to expand its high throuput testing by installing new tools from Illumina, Applied Biosystems and Luminex.
Monday, February 26, 2007
Expression Analysis Announces its Participation in the First Phase of the MAQC Project
This first phase of the MAQC Project was focused on reproducibility of results among seven microarray platforms and three other gene expression platforms.
Wednesday, September 13, 2006
Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
Diagnostic Test Developed for Enterovirus D68
researchers at Washington University School of Medicine in St. Louis have developed a diagnostic test to quickly detect enterovirus D68 (EV-D68), a respiratory virus that caused unusually severe illness in children last year.
How a Kernel Got Naked and Corn Became King
Ten thousand years ago, a golden grain got naked, brought people together and grew to become one of the top agricultural commodities on the planet.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
New Material Opens Possibilities for Super-Long-Acting Pills
A pH-responsive polymer gel could create swallow able devices, including capsules for ultra-long drug delivery.
How To Keep Your Rice Arsenic-Free
Researchers at Queen’s University Belfast have made a breakthrough in discovering how to lower worrying levels of arsenic in rice that is eaten all over the world.
New Tool For Investigating RNA Gone Awry
A new technology – called “Sticky-flares” – developed by nanomedicine experts at Northwestern University offers the first real-time method to track and observe the dynamics of RNA distribution as it is transported inside living cells.
Computer Model Could Explain how Simple Molecules Took First Step Toward Life
Two Brookhaven researchers developed theoretical model to explain the origins of self-replicating molecules.
New Tech Enables Epigenomic Analysis with a Mere 100 Cells
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer has been developed by researchers at Virginia Tech.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!